After more than a decade of research and development, Tokyo Electron Miyagi Ltd. has introduced an innovative semiconductor ...

Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the advancement of its matrix metalloproteinase-9 (MMP9) ...

This article explores the US and EU compliance requirements to ensure patient safety for GMP ancillary materials in cell and ...

The Cellares Cell Shuttle platform was the first to receive the FDA’s Advanced Manufacturing Technology (AMT) designation, which offers partners additional touchpoints and priority review mechanisms ...

A new nuclear fuel plant rising in Tennessee is turning a once-esoteric technology into a cornerstone of the energy ...

Use this brand-new eBook from Cytiva to learn more about the oligonucleotide market as a whole and about the full workflow solutions available today. We hope you enjoy it!

Alnylam's $250 million investment will enhance its Norton, Massachusetts facility with an enzymatic ligation platform to meet ...

New platform is expected to substantially increase manufacturing capacity and lower production costs, enabling investment in expanding pipeline FDA has accepted Alnylam’s enzymatic ligation ...

Dong-A Socio Group is targeting the global market with a diversified strategy encompassing new drug development, raw pharmaceutical CDMO (contract development and manufacturing organization), ...

The "Oligonucleotide Synthesis Market Industry Trends and Global Forecasts to 2035: By Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, ...